Future studies will provide more insight into how CLRs are involved in various diseases and how to exploit the interactions between the commensal fungal populations and immune responses in the gut to treat related diseases, including IBD and colon cancer. The gene discussed is LARS1; the disease is inflammatory bowel disease.